Literature DB >> 24342479

Evaluation of the accuracy and ease of use of a rapid HIV-1 Antibody Test performed by untrained operators at the point of care.

Richard A Galli1, Kevin F Green2, Anthony La Marca3, Lawrence F Waldman4, Ronald E Powers5, Amelia C Daly2, Christopher R Shackleton2.   

Abstract

BACKGROUND: For broader utilization of rapid HIV antibody assays in point-of-care (POC) settings, methods should be simple enough to be performed with accuracy by untrained test providers, using only the test manufacturer's written instructions.
OBJECTIVE: To demonstrate that the INSTI HIV-1 Antibody Test is simple and accurate enough to be successfully run by untrained operators in a POC setting. STUDY
DESIGN: A prospective study was conducted to compare the results of the FDA-cleared, INSTI HIV-1 Antibody Test (INSTI, bioLytical Laboratories Inc., Richmond, BC, Canada) used by untrained operators on finger-stick whole blood to results obtained by trained laboratory professionals using FDA-cleared comparator methods (CM) on matching venous blood. A total of 1388 subjects were recruited into the study in three diverse US POC sites. One central laboratory was used for CM testing. Untrained operators and experienced laboratory professionals also conducted a study on prepared plasma specimens to compare limit of detection (LoD) abilities.
RESULTS: Of the 517 HIV positive subjects (34 new positives and 483 known positives) the concordance between INSTI performed by untrained operators and CM performed by trained laboratory professionals was 100% (95% CI=99.3-100%). Concordance for HIV negative results (n=871) was 99.8% (95% CI=99.2-99.9%). There were no significant differences in INSTI limit of detection between untrained operators and laboratory professionals.
CONCLUSIONS: Untrained operators with no laboratory background were able to perform and interpret the results of INSTI on finger-stick blood and LoD specimens with a high degree of accuracy by following only the manufacturer's written instructions.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; Ease-of-use; HIV; Point-of-care; Rapid; Test

Mesh:

Substances:

Year:  2013        PMID: 24342479     DOI: 10.1016/j.jcv.2013.08.024

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  6 in total

1.  Field performance of the INSTI HIV-1/-2 antibody test in two South African antenatal clinics.

Authors:  Simnikiwe H Mayaphi; Desmond J Martin; Thomas C Quinn; Anton C Stoltz
Journal:  J Med Virol       Date:  2019-03-18       Impact factor: 2.327

2.  The "No Wrong Door" Approach to HIV Testing: Results From a Statewide Retail Pharmacy-Based HIV Testing Program in Virginia, 2014-2016.

Authors:  Bryan Collins; Heather Bronson; Fatima Elamin; Lauren Yerkes; Elaine Martin
Journal:  Public Health Rep       Date:  2018 Nov/Dec       Impact factor: 2.792

Review 3.  Aspects of Point-of-Care Diagnostics for Personalized Health Wellness.

Authors:  Sandeep Kumar; Monika Nehra; Sakina Khurana; Neeraj Dilbaghi; Vanish Kumar; Ajeet Kaushik; Ki-Hyun Kim
Journal:  Int J Nanomedicine       Date:  2021-01-14

4.  Implementation of Novel Quality Assurance Program for Hepatitis C Viral Load Point of Care Testing.

Authors:  Wayne Dimech; Liza Cabuang; Kylie Davies; Giuseppe Vincini
Journal:  Viruses       Date:  2022-08-30       Impact factor: 5.818

5.  Laboratory Evaluation of a Point-of-Care Downward-Flow Assay for Simultaneous Detection of Antibodies to Treponema pallidum and Human Immunodeficiency Virus.

Authors:  S Herbst de Cortina; C C Bristow; S K Vargas; D G Perez; K A Konda; C F Caceres; J D Klausner
Journal:  J Clin Microbiol       Date:  2016-05-04       Impact factor: 5.948

6.  Quantification of plasma HIV RNA using chemically engineered peptide nucleic acids.

Authors:  Chao Zhao; Travis Hoppe; Mohan Kumar Haleyur Giri Setty; Danielle Murray; Tae-Wook Chun; Indira Hewlett; Daniel H Appella
Journal:  Nat Commun       Date:  2014-10-06       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.